News of the WeekGLYCOBIOLOGY

Synthetic Vaccine Is a Sweet Victory for Cuban Science

See allHide authors and affiliations

Science  23 Jul 2004:
Vol. 305, Issue 5683, pp. 460
DOI: 10.1126/science.305.5683.460

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

On page 522, a Cuban-Canadian team reports the first large-scale production and clinical testing of a synthetic polysaccharide vaccine, one that targets the bacterium Haemophilus influenzae type B, a major cause of meningitis in young children.